UTMD Hits 96 Composite: What the 5-Factor Engine Sees

The Setup

U.S. equity markets are dark for the July 4th federal holiday — UTMD's last print is $72.78 on 0% change, a flat tape by definition rather than conviction. But the QuantLogix 5-factor signal engine ran its full universe sweep regardless, and Utah Medical Products landed at the top of the conviction list with a 96/100 composite Strong Buy — two full points clear of second-ranked HRMY at 94/100. Across the full sweep, the engine tagged 563 tickers Strong Buy against only 83 Strong Sell, a 6.8-to-1 bullish skew. UTMD did not merely score well in a bearish tape; it scored at the top of a broadly constructive signal environment. The next actionable window is the July 7 open.

The Read

Start with what a 96/100 actually means. The QuantLogix composite aggregates five independent factor models — value, momentum, quality, growth, and technical — into a single 0–100 score. A near-maximum reading like 96 means all or nearly all of those factors are simultaneously aligned to the bullish side. That kind of factor convergence is statistically uncommon. Most names score well on one or two factors and are compromised on the others. When five independent lenses all point the same direction on the same name, that is the engine flagging something structurally interesting, not a noise event.

The company profile matters for understanding why the signal is credible here. Utah Medical Products is a small-cap specialty medical device manufacturer — neonatal and obstetric care is its historical core. What distinguishes it from typical small-cap medtech is a long track record of profitability, consistent dividends, and notably low institutional coverage relative to sector peers. That last detail is the key. Low analyst coverage historically correlates with larger gaps between intrinsic value and market price — the market simply has fewer eyes on it. The engine may be detecting a mispricing that the consensus has not yet moved to close.

This maps directly onto the Anti-Index Mindset framework. The largest opportunity sets in value investing sit precisely where index funds and institutional capital structurally underweight: small-cap, low analyst coverage, less-trafficked corners of a sector. A name with a 96/100 composite in that structural setting is more interesting than the same score on a mega-cap with dozens of sell-side analysts covering every quarter. The crowd has not arrived yet — which is both the opportunity and the reason the signal requires independent verification before capital is committed.

The 6.8-to-1 breadth ratio (563 Strong Buys vs. 83 Strong Sells) provides regime context. Any individual signal is more credible when the engine is detecting broad underlying strength across the universe than when it surfaces as a lone outlier in a bearish sweep. UTMD's #1 ranking in a constructive broad environment reads differently than the same score in a tape where hundreds of names are flashing Sell. That said, the absence of index-level data today — a direct consequence of the holiday close — means macro regime confirmation needs to be sourced from the most recent pre-holiday Market Pulse. The factor engine runs on fundamental and technical inputs that do not require intraday index feeds, but disciplined investors confirm, they do not assume.

On position sizing, the Illiquidity Discipline from Position Sizing by Conviction × Liquidity applies directly here. UTMD is a small-cap. Before any sizing decision, check the float and average daily volume. High conviction in a thin name does not justify large-cap sizing — if exit cost in a stress scenario would materially impact price over a short window, the position should be smaller than conviction alone would suggest. Illiquidity is a tax that compounds precisely when the investor most needs to manage risk.

The Action

• Add UTMD to your watchlist before the July 7 open and set a price alert at $72.78 — the signal is forward-looking and requires price and volume confirmation from the first session post-holiday before capital is committed.
• Review the QuantLogix UTMD signal detail page to identify which of the five factors — value, momentum, quality, growth, technical — is carrying the most weight in the 96/100 composite; the factor breakdown is the basis for your thesis, not the composite number alone.
• Cross-check the 563:83 Strong Buy-to-Sell breadth ratio against the regime tag on the July 7 Market Pulse to confirm macro conditions support acting on high-conviction individual names — a bullish signal in a deteriorating regime requires a smaller initial position and tighter drawdown discipline.
• Define your invalidation level before entry: if the composite score begins fading toward 80 or below within the first week post-entry, treat that deterioration as a stop-signal rather than a re-entry opportunity — thesis violation is a sell trigger, not a pause.
• Do not treat a 96/100 composite as a price-target guarantee — use it as a prioritization filter that earns UTMD a place at the top of your fundamental due-diligence queue: earnings history, dividend record, float, and capital structure before sizing up.

The Counter

The sharpest pushback: a 96/100 composite is a crowded-signal risk. Names at extreme readings may already have the factor tailwinds priced in, leaving little asymmetry for a new entrant at $72.78. This argument has real teeth in large-cap, heavily-covered names — but it loses force in a name with UTMD's profile. Low institutional coverage means there are structurally fewer actors who have already responded to the same quantitative signals. The gap between intrinsic value and market price tends to be wider where fewer analysts are looking. The Information Edge framework applies here in reverse: individual investors have a structural information disadvantage versus institutions in efficient markets, but in a low-coverage small-cap, that disadvantage narrows considerably. The second counter — that today's 0% move and closed-market breadth give no real-time price confirmation — is accurate and important. This is a pre-open research alert, not a live execution trigger. The discipline is to treat July 4 as thesis-formation time and July 7's first 30–60 minutes of volume and price action as the confirmation gate. Behavioral Edge — the willingness to do the work now and act with discipline on July 7 rather than chase intraday — is precisely where the retail investor has a structural advantage over participants forced to act on shorter clocks.

Primary Sources

• UTMD Signal Detail — QuantLogix Live Dashboard — QuantLogix, 2026-07-04
• Utah Medical Products Inc. — SEC EDGAR Filing Page — U.S. Securities and Exchange Commission
• UTMD Investor Relations — Utah Medical Products, Inc.
• UTMD Historical Financials and Dividend History — to be sourced via Macrotrends or Wisesheets